President Joe Biden has set a new target for at least 70% of adults to be partially vaccinated against COVID-19 by July 4.
Associated Press, USA TODAY
To meet his new goal of ensuring that 70% of American adults receive at least one dose of the vaccine by July 4, President Joe Biden on Tuesday presented a plan to make vaccinations more convenient and to convince those who are reluctant to get vaccinated.
More than 147 million Americans, including 56% of those 18 and over, have received at least one dose of the vaccine and nearly a third of the population has been fully immunized. But with polls showing that about 25% are not planning on getting the vaccine, Biden admitted, “Now we’re going to have to get the vaccine to people who are less willing. “
Also in the news:
►President Joe Biden wants 70% of American adults to have received at least one COVID-19 vaccine by July 4, a target he is expected to announce on Tuesday, along with new measures to vaccinate more difficult populations to reach and preparations to vaccinate adolescents. Currently, 56.3% of American adults have received at least one dose.
►Oklahoma Governor Kevin Stitt, a Republican who tested positive in July, lifted the state’s COVID-19 emergency declaration as of Tuesday, citing data showing a drop in new cases and hospitalizations.
►New Jersey Gov. Phil Murphy announced a “Shot and Beer” program allowing drinking-age residents of the state who receive their first dose of a COVID-19 vaccine this month a free beer in one of the state’s 13 craft breweries.
►South Korean officials have said that North Korea has told Asian football’s governing body that they will not be making the World Cup qualifiers due to take place in South Korea next month due to coronavirus problems.
📈 Numbers of the day: The United States has more than 32.47 million confirmed cases of coronavirus and 577,500 deaths, according to data from Johns Hopkins University. Global totals: over 153.18 million cases and 3.2 million deaths. More than 312.5 million doses of the vaccine have been distributed in the United States and 246.7 million have been administered, according to the CDC. More than 105.5 million Americans have been fully immunized.
Keep refreshing this page for the latest updates. Want more? Sign up for our Coronavirus Watch newsletter for updates to your inbox and join our Facebook group.
The Biden administration will begin allocating doses of the vaccine out of states with low demand to those where demand remains high, an administration official said on Tuesday.
The vaccination rush has abated across much of the country, with some states refusing all or part of their weekly dose allocations. The federal government will now transfer some of these doses to areas where appointments remain difficult to obtain.
The United States is reporting first-dose vaccine injections at less than half the rate of just a few weeks ago, according to a USA TODAY analysis of CDC data. The government reported administering 6.54 million first doses in the week ending Monday, down sharply from the 14 million reported in the week ending April 13. On Monday alone, the country reported about 471,000 first doses, the lowest number since Feb. 23, when an ice storm thundered supplies.
More than 147 million Americans, or 44% of the American population, have received at least one dose. Herd immunity is estimated to require vaccination of 70% or more of the population. More than a quarter of all Americans say they don’t want the vaccine, polls show.
The good news: Some experts say it may not take ‘herd immunity’ to see a dramatic drop in COVID-19 cases, which 30-40 million additional first vaccines could be enough for the United States to achieve a vaccine tipping point and contain the pandemic.
Struggles to secure strong commitments for vaccine procurement have left Europe far behind vaccination campaigns in the United States and Britain.
“Vaccination is gaining speed across the EU: we have just passed 150 million vaccinations,” vod der Leyen tweeted in several languages. “We will have enough doses to vaccinate 70% of adults in the EU by July.”
While cases are increasing in some states, they are decreasing nationally. Perhaps most importantly, they drop rapidly in the highly immunized age groups.
Among Americans 65 and older, who are most vulnerable to the disease, 70% are fully immunized. They are 94% less likely to be hospitalized with COVID-19 than people the same age who are not vaccinated, a CDC report showed last week.
“When you’re about 50% (vaccinated), you put significant downward pressure on cases,” said Dr. Robert Wachter, professor and head of the Department of Medicine at the University of California-San Francisco.
– Elizabeth Way
The United States will restrict travel from India starting Tuesday following a deadly outbreak of coronavirus that broke records and left the country desperate.
The country’s official tally of the total number of coronavirus cases topped 20 million on Tuesday, almost doubling in the past three months, while deaths officially topped 220,000. As staggering as these numbers are, the real numbers would be fine. higher, the undercoverage apparently reflecting the problems of the health system. Here is what we know.
Governor Ron DeSantis suspended local COVID-19 emergency orders across Florida on Monday.
Trunk – Sun Sentinel, Trunk – Sun Sentinel
The Food and Drug Administration will soon authorize the Pfizer-BioNTech COVID-19 vaccine for adolescents aged 12 to 15, who may be eligible to receive the vaccines as early as next week.
The much-anticipated move, which is expected to be backed by the CDC, would allow most middle and high school students to get vaccinated before summer camps and the start of the 2021-2022 school year.
The current age requirement for the Pfizer-BioNTech vaccine is 16, and 18 for Moderna and Johnson & Johnson vaccines. These two companies are also testing their vaccines on children under the age of 18.
In a recent trial, Pfizer-BioNTech showed 2,260 adolescents aged 12 to 15 that its two-dose vaccine was extremely safe and fully effective. Of the 16 adolescents infected with COVID-19 in the trial, all had received the placebo, none the active vaccine.
– Karen Weintraub
Contributing: Mike Stucka, USA TODAY; The Associated Press.